Tic disorders: From pathophysiology to treatment

Journal of Neurology

Volumn 253, Issue 1, 2006, Pages 1-15

  Rampello, Liborio ^c   Alvano, Alessandro ^c   Battaglia, Giuseppe ^a   Bruno, Valeria ^a,b   Raffaele, Rocco ^c   Nicoletti, Francesco ^c  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Hyperkinetic movement disorders; Tics; Tourette syndrome

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMISULPRIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; LAMOTRIGINE; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; PERGOLIDE; PHENYTOIN; PIMOZIDE; QUETIAPINE; RISPERIDONE; ROPINIROLE; TETRABENAZINE; UNINDEXED DRUG; ZIPRASIDONE;

AGRANULOCYTOSIS; ANXIETY; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; DISEASE EXACERBATION; DOPAMINERGIC SYSTEM; DROWSINESS; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; GILLES DE LA TOURETTE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPERTRIGLYCERIDEMIA; IRRITABILITY; METABOLIC DISORDER; MOOD CHANGE; MOTOR DYSFUNCTION; MYOCLONUS; NEUROANATOMY; NEUROCHEMISTRY; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROSURGERY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PATHOPHYSIOLOGY; PHYSICIAN; PRIORITY JOURNAL; PSYCHOTHERAPY; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SPEECH DISORDER; STEREOTYPY; STUTTERING; TARDIVE DYSKINESIA; THALAMOCORTICAL TRACT; TIC; WEIGHT GAIN;

HUMANS; TIC DISORDERS;

EID: 31544481197     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0008-8     Document Type: Review

References (163)

1. Adams JR, Troiano AR, Calne DB (2004) Functional imaging in Tourette's syndrome. J Neural Transm 111:1495-1506
2. Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA (2003) Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310-315
3. Allen AJ (1997) Group streptococcal infections and childhood neuropsychiatric disorder. Curr Opin 267:75
4. Almeras N, Despres JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH (2004) Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 65:557-564
5. Alsobrook JP, Pauls DL (1997) The genetics of Tourette syndrome. Neurol Clin 15:381-893
6. Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U (2003) EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641-646
7. th ed. Washington, DC: American Psychiatric Assn 103
8. Anca MH, Giladi N, Korczyn AD (2004) Ropinirole in Gilles de la Tourette syndrome. Neurology 62:1626-1627
9. Awaad Y, Michon AM, Minarik S (2005) Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 20:714-718
10. Bagheri MM, Kerbeshian J, Burd L (1999) Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician 59:2263-2272
11. Begum M (2005) Clozapine-induced stuttering, facial tics and myoclonic seizures: a case report. Aust N Z J Psychiatry 39:202
12. Black KJ (2002) Tourette Syndrome and Other Tic Disorders Available from: http://www.eMedicine.com
13. Black KJ, Mink JW (2000) Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194-1198
14. Bonnier C, Nassogne M, Evrard P (1999) Ketanserin Treatment of Tourette's Syndrome in Children. Am J Psychiatry 156:1122-1123
15. Bruggeman R, van der Linden C, Buitelaar JK (2001) Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 62:50-56
16. Carr JE, Bailey JS (1996) A brief behavior therapy protocol for Tourette syndrome. J Behav Ther Exp Psychiatry 27:33-40
17. Chang HL, Tu MJ, Wang HS (2004) Tourette's syndrome: psychopathology in adolescents. Psychiatry Clin Neurosci 58:353-358
18. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140-1146
19. Cohen DJ, Jankovic J, Goetz CG (2001) Tourette syndrome. In: Advances in Neurology. Philadelphia, Pa: Lippincott Williams and Wilkins
20. Crawford FC, Ait-Ghezala G, Morris M, Sutcliffe MJ, Hauser RA, Silver AA, Mullan MJ (2003) Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 113:154-161
21. Cuker A, State MW, King RA, Davis N, Ward DC (2004) Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. Am J Med Genet 130:37-39
22. Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 38:571-579
23. Devor EJ, Magee HJ (1999) Multiple childhood behavioral disorders (Tourette syndrome, multiple tics, ADD, and OCD) presenting in a family with a balanced chromosome translocation (t1; 8)(q21.1;q22.1).Psychiatr Genet 9:149-151
24. Dion Y, Annable L, Sandor P, Chouinard G (2002) Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 22:31-39
25. Eapen V, Pauls DL, Robertson MM (1993) Evidence for autosomal dominant transmission in Tourette syndrome. Br J Psychiatry 162:593-596
26. Eichstedt JA, Arnold SL (2001) Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 21:137-157
27. Evidente VG (2000) Is it a tic or Tourette's? Clues for differentiating simple from more complex tic disorders. Postgraduate Medicine 108:5
28. Fahn S (1988) Blepharospasm: a form of focal dystonia. Adv Neurol 49:125-133
29. Fattapposta F, Restuccia R, Colonnese C, Labruna L, Garreffa G, Bianco F (2005) Gilles de la Tourette syndrome and voluntary movement: a functional MRI study. Psychiatry Res 138:269-272
30. Fountoulakis KN, Iacovides A, St Kaprinis G (2004) Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 38:90
31. Fredericksen KA, Cutting LE, Kates WR, Mostofsky SH, Singer HS, Cooper KL, et al. (2002) Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 58:85-89
32. Gaffney Gr, Perry PJ, Lund BC, BeverStille KA, Arndt S, Kuperman S (2002) Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 41:330-336
33. Gaulin BD, Markowitz JS, Caley CF, Nesbitt LA, Dufresne RL (1999) Clozapine-Associated Elevation in Serum Triglycerides. Am J Psychiatry 156:1270-1272
34. Gazdag G, Barna I, Ivanyi Z, Tolna J (2004) The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 57:385-390
35. Gerber PE, Lynd LD (1998) Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 32:692-698
36. Gilbert DL, Batterson JR, Sethuraman G, Sallee FR (2004) Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 43:206-214
37. Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR (2003) Tic reduction with pergolide in a randomized controlled trial in children. Neurology 60:606-611
38. Gilbert DL, Sallee FR, Zhang J, Lipps TD, Wassermann EM (2005) Transcranial Magnetic Stimulation-Evoked Cortical Inhibition: A Consistent Marker of Attention-Deficit/Hyperactivity Disorder Scores in Tourette Syndrome. Biol Psychiatry 57:1597-1600
39. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR (2000) Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 54:1310-1315
40. Goetz CG, Chmura TA, Lanska DJ (2001) History of tic disorders and Gilles de La Tourette syndrome: Part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona. Mov Disord 16:346-349
41. Graybiel AM, Rauch SL (2000) Toward a neurobiology of obsessivecompulsive disorder. Neuron 28:343-347
42. Hallett JJ, Harling-Berg CJ, Knopf PM, Stopa EG, Kiessling LS (2000) Antistriatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111:195-202
43. Hallett M (2001 ) Neurophysiology of tics. Adv Neurol 85:237-244
44. Hamilton CS, Garvey MA, Swedo SE (2001) Therapeutic implications of immunology for tics and obsessive-compulsive disorder. Adv Neurol 85:311-318
45. Hanna PA, Janjua FN, Contant CF (1999) Bilineal transmission in Tourette syndrome. Neurology 53:813-818
46. Hanna PA, Jankovic J (2002) Sleep and tic disorders. In: Chokroverty S, Hening Walters A (eds) Sleep and movement disorders. Woburn, Mass Butterworth-Heinemann, pp 181-189
47. Hoekstra PJ, Anderson GM, Limburgc PC, Korfd J, Kallenbergc CGM, Minderaa RB (2004) Neurobiology and neuroimmunology of Tourette's syndrome: an update
48. Hornsey H, Banerjee S, Zeitlin H, Robertson M (2001) The prevalence of Tourette syndrome in 13-14-year-olds in mainstream schools. J Child Psycol Psychiatry 42:1035-1039
49. Horrigan JP, Barnhill LJ (1995) Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 5:215-223
50. Hunt RD, Arnsten AFT, Asbell MD (1995) An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50-54
51. Hyde TM, Aaronson BA, Randolph C, Rickler KC, Weinberger DR (1992) Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 42:652-658
52. Jankovic J (1997) Tourette syndrome: phenomenology and classification of tics. Neurol Clin 15:267-275
53. Jankovic J (2001) Tourette's syndrome. N Engl J Med 345:1184-1192
54. Jankovic J (2001) Differential diagnosis and etiology of tics. Adv Neurol 85:15-29
55. Jimenez-Jimenez FJ, Garcia-Ruiz PJ (2001) Pharmacological options for treatment of Tourette's disorder. Drugs 61:2207-2220
56. Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K, Mazur-Hopkins P, Kofman O, Singer HS, Denckla MB, Pearlson GD, Kaufmann WE (2002) MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 116:63-81
57. Kiessling LS, Marcotte AC, Culpepper L (1993) Antineuronal antibodies in movement disorders. Pediatrics 92:39-43
58. King RA, Scahill L (2001) Emotional and behavioral difficulties associated with Tourette syndrome. Adv Neurol 85:79-88
59. Kofoed L, Tadepalli G, Oesterheld JR, Awadallah S, Shapiro R (1999) Case series: clonidine has no systematic effects on PR or QTc intervals in children. J Am Acad Child Adolesc Psychiatry 38:1193-1196
60. Kossoff EH, Singer HS (2001) Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 3:355-363
61. Kumar R, Lang AE (1997) Tourette syndrome. Secondary tic disorders. Neurol Clin 15:309-331
62. Kurlan K, Lichter D, Hewitt D (1989) Sensory tics in Tourette's Syndrome. Neurology 39:731-734
63. Kurlan R, Como PG, Miller B (2002) The behavioural spectrum of tic disorders: a community-based study. Neurology 59:414-420
64. Kurlan R (1997) Tourette syndrome. Treatment of tics. Neurol Clin 15:403-409
65. Kurlan R (1998) Tourette's syndrome and 'PANDAS': Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology 50:1530-1534
66. Kwak C, Dat VK, Jankovic J (2003) Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 18:1530-1533
67. Kwak C, Vuong KD, Jankovic J (2003) Migraine headache in patients with Tourette syndrome. Arch Neurol 60:1595-1598
68. Kwak CH, Hanna PA, Jankovic J (2000) Botulinum toxin in the treatment of tics. Arch Neurol 57:1190-1193
69. Lang AE (1991) Patient perception of tics and other movement disorders. Neurology 41:223-228
70. Lang AE (2001) Update on the treatment of tics. Adv Neurol 85:355-362
71. Lebovitz HE (2003) Metabolic consequences of atypical antipsychotic drugs. Psychiatr Q Fall 74:277-290
72. Leckman JF, Cohen DJ (1988) Descriptive and diagnostic classification of tic disorders. In: Cohen DJ, Bruun RD, Leckman JF (eds) Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley and Sons, pp 3-21
73. Leckman JF, Cohen DJ (1999) Tourette's syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York: John Wiley and Sons
74. Leckman JF, Dolnansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, et al. (1990) Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 29:220-226
75. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324-328
76. Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 57:667-673
77. Leckman JF, Peterson BDS, Anderson GM, Arnsten ATF, Pauls DL, Cohen DJ (1997) Pathogenesis of Tourette's syndrome. J Child Psychol Psychiatry 38:119-142
78. Leckman JF, Peterson BS, King RA (2001) Phenomenology of tics and natural history of tic disorders. Adv Neurol 85:1-14
79. Leckman JF, Peterson BS, Pauls DL, Cohen DJ (1997) Tic disorders. Psychiatr Clin North Am 20:839-861
80. Leckman JF, Riddle MA (2000) Tourette's syndrome: when habit-forming systems form habits of their own? Neuron 28:349-354
81. Leckman JF, Walker DE, Cohen DJ (1993) Premonitory urges in Tourette's syndrome. Am J Psychiatry 150:98-102
82. Lesperance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F; Montreal Tourette Study Group (2004) Restless legs in Tourette syndrome. Mov Disord 19:1084-1087
83. Marcus D, Kurlan R (2001) Tics and its disorders. Neurol Clin 19:735-758
84. Marras C, Andrews D, Sime E, Lang AE (2001) Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 56:605-610
85. Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, et al. (2000) Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008-1013
86. Mink JW (2003) The basal ganglia and involuntary movements. Arch Neurol 60:1365-1368
87. Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381-425
88. Mink JW (2001) Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 85:113-122
89. Morshed SA, Parveen S, Leckman JF (2001) Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 50:566-577
90. Mukaddes NM, Abali O (2003) Quetiapine treatment of children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 13:295-299
91. Mullen N, Riedel M, Straube A, Gunther W, Wilske B (2000) Increased anti-streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res 94:43-49
92. Muller N (2004) Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndrome. Inflammopharmacology 12:271-275
93. Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele-Horn M (2004) Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 129:119-125
94. Muller-Vahl KR (2002) The treatment of Tourette's syndrome: current opinions. Expert Opin Pharmacother 3:899-914
95. Muller-Vahl KR (2003) Cannabinoids reduce symptoms of Tourette's syndrome. Expert Opin Pharmacother 4:1717-1725
96. Muller-Vahl KR, Kolbe H, Schneider U (1999) Cannabis in movement disorders. Forsch Komplementarmed 6:23-27
97. Muller-Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brucke T, Berding G (2005) Serotonin transporter binding in Tourette Syndrome. Neurosci Lett (Epub ahead of print)
98. Muller-Vahl KR, Prevedel H, Theloe K, Kolbe H, Emrich HM, Schneider U (2003) Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. Neuropsychopharmacology 28:384-388
99. Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M (2005) Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 28:1-2
100. Murphy TK, Goodman WK, Fudge MW (1997) B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 154:402-407
101. Niederhofer H, Staffen W, Mair A (2003) A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. J Psychopharmacol 17:113-119
102. Nordstrom EJ, Burton FH (2002) A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 7:524
103. Olson S (2004) Neurobiology. Making sense of Tourette's. Science 305:1390-1392
104. Onofrj M, Paci G, D'Andrea M, Toma L (2000) Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 247:443-446
105. Orth M, Amann B, Robertson MM, Rothwell JC (2005) Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 128:292-1300
106. Parraga HC, Parraga MI, Woodward RL, Fenning PA (2003) Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Am Acad Child Adolesc Psychiatry 42:623-624
107. Paschou P, Feng Y, Pakstis AJ, Speed WC, DeMille MM, Kidd JR, Jaghori B, Kurlan R, Pauls DL, Sandor P, Barr CL, Kidd KK (2004) Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. Am J Hum Genet 75:545-560
108. Pauls DL (2001) Update on the genetics of Tourette syndrome. Adv Neurol 85:281-293
109. Pauls DL (2003) An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 55:7-12
110. Perlmutter SJ, Garvey MA, Castellanos X, Mittleman BB, Giedd J, Rapoport JL, Swedo SE (1998) A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 155:1592-1598
111. Perry P, Gaffney G Pediatric Psychopharmacology: Tourette's Syndrome. Clinical Psychopharmacology Seminar 1996 Peer Review. Available from: http://www.vh.org/Providers/Conferences/CPS/42.html
112. Peterson AL, Azrin NH (1992) An evaluation of behavioral treatments for Tourette syndrome. Behav Res Ther 30:167-174
113. Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, King RA, Leckman JF, Staib L (2003) Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415-424
114. Plessen KJ, Wentzel-Larsen T, Hugdahl K, Feineigle P, Klein J, Staib LH, Leckman JF, Bansal R, Peterson BS (2004) Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry 161:2028-2037
115. Pogarell O, Juckel G, Mulert C, Amann B, Möller HJ, Heger U (2004) EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol. Pharmacopsychiatry 37:304-305
116. Porta M, Maggioni G, Ottaviani F, Schindler A (2004) Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A Neurol Sci 24:420-423
117. Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ (2004) Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14:233-241
118. Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A (1998) Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 21:97-100
119. Raffaele R, Vecchio I, Alvano A, Proto G, Nicoletti G, Rampello L (2004) Blink reflex abnormalities in Tourette sindrome. Clin Neurophysiol 115:320-324
120. Rampello L, Nicoletti G, Vecchio I (1995) Clinical and evolutive aspects of Tourette's syndrome. J Neurol 242:88
121. Rampello L, Vecchio I, Furnari P (2000) Tourette's sindrome: phenotipic and aetiopathogenetic spectrum. Mov Disord 15:248
122. Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123:425-462
123. Rothenberger A, Kostanecka T, Kinkelbur J, Cohrs S, Woerner W, Hajak G (2001) Sleep and Tourette syndrome. In: Cohen DJ, Jankovic J, Goetz CG (eds) Tourette syndrome. Vol 85 of Advances in neurology. Philadelphia: Lippincott Williams and Wilkins, pp 245-259
124. Ruth U, Mayer-Rosa J, Schlamp D, Freisleder FJ (2000) Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine. Z Kinder Jugendpsychiatr Psychother 28:105-108
125. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299
126. Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 154:1057-1062
127. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder. Am J Psychiatry 158:1067-1074
128. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003) A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130-1135
129. T L, Tanner C, Dure L (2001) The epidemiology of tics and Tourette syndrome in children and adolescents. Adv Neurol 85:261-271
130. Serrien DJ, Orth M, Evans AH, Lees AJ, Brown P (2005) Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain 128:116-125
131. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46:722-730
132. Silay YS, Jankovic J (2005) Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 10:365-380
133. Silver AA, Shytle RD, Philipp MK (2001) Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-contolled study. J Clin Psychiatry 62:707-714
134. Simonic I, Nyholt DR, Gericke, GS, Gordon D, Matsumoto N, Ledbetter DH, Ott J, Weber JL (2001) Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11,8q22, and 11q23-24 in South African Afrikaners. Am J Med Genet 105:163-167
135. Singer HS (1995) Neurobiology of Tourette syndrome Biol Psychiatry 37:629
136. Singer HS (2000) Current issues in Tourette Syndrome. Mov Disord 15:1051-1063
137. Singer HS (2005) Tourette's syndrome: from behaviour to biology. Lancet Neurol 4:149-159
138. Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS (1998) Antibodies against human putamen in children with Tourette syndrome. Neurology 50:1618-1624
139. Singer HS, Giuliano JD, Hansen BH, et al. (1999) Antibodies against a neuron-like (HTB10 neuroblastoma) cell in children with Tourette syndrome. Biol Psychiatry 46:775-780
140. Singer HS, Krumholz A, Giuliano J, Kiessling LS (1997) Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome. Mov Disord 12:738-742
141. Smith JL, Johnstone SJ, Barry RJ (2004) Inhibitory processing during the Go/NoGo task: an ERP analysis of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 115:1320-1331
142. Smith SJ, Lees AJ (1989) Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurgery Psychiatry 52:895-898
143. State MW, Greally JM, Cuker A, Bowers PN, Henegariu O, Morgan TM, et al. (2003) Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci USA 100:4684-4689
144. Stein DJ (2002) Obessive-compulsive disorder. Lancet 360:397-405
145. Stephens RJ, Bassel C, Sandor P (2004) Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. J Child Adolesc Psychopharmacol 14:255-266
146. Stern JS, Burza S, Robertson MM (2005) Gules de la Tourette's syndrome and its impact in the UK. Postgrad Med J 81:12-19
147. Tatlipinar S, Iener EC, Ilhan B (2001) Ophtalmic manifestations of Gilles de la Tourette syndrome. Eur Ophtalmol 11:223-226
148. Temel Y, Visser-Vandewalle V (2004) Surgery in Tourette syndrome. Mov Disord 19:3-14
149. The Tourette Syndrome Association International Consortium for Genetics (1999) A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65:1428-1436
150. The Tourette Syndrome Classification Study Group (1993) Definitions and classification of tic disorders. Arch Neurol 50:1013-1016
151. Tolchard B (1995) Treatment of Gilles de la Tourette syndrome using behavioural psychotherapy: a single case example. J Psychiatr Ment Health Nurs 2:233-236
152. Toren P, Toren A, Weizman A, Mozes T, Eldar S, Magor A, Mandel M, Rechavi G, Many A, Mester R (1994) Tourette's disorder: is there an association with the antiphospholipid syndrome? Biol Psychiatry 35:495-498
153. Toren P, Weizman A, Ratner S, Cohen D, Laor N (2005) Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 66:499-503
154. Tourette's Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527-536
155. Vandewalle V, van der Linden C, Groenewegen HJ (1999) Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353:724
156. Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA (2004) Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 42:501-511
157. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA, and the Tourette Syndrome Association International Consortium for Genetics (2003) CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82:1-9
158. Voelker R (2004) Scientists use neuroimaging, genetic studies to probe biology of tourette syndrome. JAMA 292:909-911
159. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O (1996) Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 59:684-693
160. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L (2003) Habit Reversal Versus Supportive Psychotherapy for Tourette's Disorder: A Randomized Controlled Trial. Am J Psychiatry 160:1175-1177
161. Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, et al. (1996) Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225-1227
162. Woods DW, Twohig MP, Flessner CA, Roloff TJ (2003) Treatment of vocal tics in children with Tourette syndrome: investigating the efficacy of habit reversal. J Appl Behav Anal 36:109-112
163. Zhang H, Leckman JF, Pauls DL, Tsai CP, Kidd KK, Campos MR (2002) Genome wide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 70:896-904